• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Human serum carnosinase: characterization, distinction from cellular carnosinase, and activation by cadmium.

作者信息

Lenney J F, George R P, Weiss A M, Kucera C M, Chan P W, Rinzler G S

出版信息

Clin Chim Acta. 1982 Aug 18;123(3):221-31. doi: 10.1016/0009-8981(82)90166-8.

DOI:10.1016/0009-8981(82)90166-8
PMID:7116644
Abstract

Human serum carnosinase was assayed using a simple and sensitive fluorometric method. Under optimum conditions, the average adult serum hydrolyzed 42 mu mol of carnosine per ml per hour, about 17 times the average activity reported in the literature. Cadmium was twice as effective as manganese as an activator of this enzyme. Serum carnosinase was found to be different in many respects from cellular carnosinase. For example, the serum isozyme hydrolyzed homocarnosine, whereas the cellular carnosinase did not. The apparent molecular weight of serum carnosinase was 160 000, while that of the cellular isozyme was 90 000. Although it has been reported that serum contains two molecular forms of carnosinase, only one form was detected using several electrophoretic methods and two ion exchange chromatography procedures. The concentration of serum carnosinase varied greatly between individuals. Little or no enzyme was detected in children below 10 months in age. Thereafter, the average concentration of carnosinase increased gradually to reach the adult range at age 13-15.

摘要

相似文献

1
Human serum carnosinase: characterization, distinction from cellular carnosinase, and activation by cadmium.
Clin Chim Acta. 1982 Aug 18;123(3):221-31. doi: 10.1016/0009-8981(82)90166-8.
2
Separation and characterization of two carnosine-splitting cytosolic dipeptidases from hog kidney (carnosinase and non-specific dipeptidase).从猪肾中分离和鉴定两种分解肌肽的胞质二肽酶(肌肽酶和非特异性二肽酶)。
Biol Chem Hoppe Seyler. 1990 May;371(5):433-40. doi: 10.1515/bchm3.1990.371.1.433.
3
Characterization of human tissue carnosinase.人组织肌肽酶的特性分析
Biochem J. 1985 Jun 15;228(3):653-60. doi: 10.1042/bj2280653.
4
Homocarnosinosis: lack of serum carnosinase is the defect probably responsible for elevated brain and CSF homocarnosine.同型肌肽血症:血清肌肽酶缺乏可能是导致脑和脑脊液中同型肌肽升高的缺陷原因。
Clin Chim Acta. 1983 Aug 15;132(2):157-65. doi: 10.1016/0009-8981(83)90243-7.
5
Purification and properties of human serum carnosinase.
Clin Chim Acta. 1991 Feb 15;196(2-3):193-205. doi: 10.1016/0009-8981(91)90073-l.
6
Human cytosolic carnosinase: evidence of identity with prolinase, a non-specific dipeptidase.人胞质肌肽酶:与脯氨肽酶(一种非特异性二肽酶)相同的证据。
Biol Chem Hoppe Seyler. 1990 Feb;371(2):167-71.
7
Relevance of allosteric conformations and homocarnosine concentration on carnosinase activity.变构构象和同型瓜氨酸浓度对肌肽酶活性的相关性。
Amino Acids. 2010 May;38(5):1607-15. doi: 10.1007/s00726-009-0367-z. Epub 2009 Nov 14.
8
Serum carnosinase activities in patients with alcoholic chronic skeletal muscle myopathy.
Clin Sci (Lond). 1988 Aug;75(2):185-90. doi: 10.1042/cs0750185.
9
Characterization of two carnosine-degrading enzymes from rat brain. Partial purification and characterization of a carnosinase and a beta-alanyl-arginine hydrolase.大鼠脑中两种肌肽降解酶的特性研究。一种肌肽酶和一种β-丙氨酰精氨酸水解酶的部分纯化及特性分析。
Eur J Biochem. 1986 Nov 3;160(3):605-13. doi: 10.1111/j.1432-1033.1986.tb10081.x.
10
Specificity and distribution of mammalian carnosinase.哺乳动物肌肽酶的特异性和分布
Biochim Biophys Acta. 1976 Mar 11;429(1):214-9. doi: 10.1016/0005-2744(76)90044-9.

引用本文的文献

1
Exploring Secondary Amine Carnosine Derivatives: Design, Synthesis, and Properties.探索仲胺肌肽衍生物:设计、合成与性质。
Molecules. 2024 Oct 28;29(21):5083. doi: 10.3390/molecules29215083.
2
A comprehensive review on physiological and biological activities of carnosine: turning from preclinical facts to potential clinical applications.肌肽的生理和生物学活性综述:从临床前事实到潜在临床应用
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1341-1366. doi: 10.1007/s00210-024-03427-7. Epub 2024 Sep 20.
3
PEGylation renders carnosine resistant to hydrolysis by serum carnosinase and increases renal carnosine levels.
聚乙二醇化使肌肽抵抗血清肌肽酶的水解,并增加肾脏肌肽水平。
Amino Acids. 2024 Jul 4;56(1):44. doi: 10.1007/s00726-024-03405-6.
4
State of the Art in the Development of Human Serum Carnosinase Inhibitors.人血清瓜氨酸酶抑制剂研发的最新进展。
Molecules. 2024 May 24;29(11):2488. doi: 10.3390/molecules29112488.
5
Dual Effect of Carnosine on ROS Formation in Rat Cultured Cortical Astrocytes.肌肽对大鼠皮质星形胶质细胞 ROS 形成的双重影响。
Mol Neurobiol. 2024 Jul;61(7):4908-4922. doi: 10.1007/s12035-023-03880-0. Epub 2023 Dec 28.
6
The Anti-Cancer Activity of the Naturally Occurring Dipeptide Carnosine: Potential for Breast Cancer.天然二肽肌肽的抗癌活性:乳腺癌的潜在治疗作用。
Cells. 2023 Nov 8;12(22):2592. doi: 10.3390/cells12222592.
7
The therapeutic potential of carnosine: Focus on cellular and molecular mechanisms.肌肽的治疗潜力:聚焦于细胞和分子机制。
Curr Res Pharmacol Drug Discov. 2023 Mar 7;4:100153. doi: 10.1016/j.crphar.2023.100153. eCollection 2023.
8
Carnosine and Beta-Alanine Supplementation in Human Medicine: Narrative Review and Critical Assessment.肌肽和β-丙氨酸在人类医学中的补充:叙事综述和批判性评估。
Nutrients. 2023 Apr 5;15(7):1770. doi: 10.3390/nu15071770.
9
The Therapeutic Potential of Carnosine as an Antidote against Drug-Induced Cardiotoxicity and Neurotoxicity: Focus on Nrf2 Pathway.肌肽作为一种对抗药物性心脏毒性和神经毒性的解毒剂的治疗潜力:聚焦 Nrf2 通路。
Molecules. 2022 Jul 12;27(14):4452. doi: 10.3390/molecules27144452.
10
The Potential Use of Carnosine in Diabetes and Other Afflictions Reported in Long COVID Patients.肌肽在新冠长期症状患者所报告的糖尿病及其他疾病中的潜在用途。
Front Neurosci. 2022 Jun 22;16:898735. doi: 10.3389/fnins.2022.898735. eCollection 2022.